Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
21.99
-0.03 (-0.11%)
Jul 22, 2024, 10:10 AM EDT - Market open
Enliven Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$33.00
Upside
+50.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +45.55% | Jun 11, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +54.65% | Apr 9, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +22.81% | Mar 29, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |